Verrica Pharmaceuticals, Inc. (VRCA)
7.97
-0.33
(-3.98%)
USD |
NASDAQ |
Dec 12, 16:00
7.77
-0.20
(-2.51%)
After-Hours: 16:29
Verrica Pharmaceuticals EPS Diluted (Quarterly): -0.0289 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
| Oragenics, Inc. | -1.965 |
| NanoViricides, Inc. | -0.1045 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.274M |
| Revenue (Quarterly) | 14.34M |
| Total Expenses (Quarterly) | 14.62M |
| Enterprise Value | 91.41M |
| Gross Profit Margin (Quarterly) | 92.27% |
| Profit Margin (Quarterly) | -1.91% |
| Earnings Yield | -31.58% |
| Normalized Earnings Yield | -27.82 |